Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's issuing a voluntary medical device correction for some of its FreeStyle ...
24/7 Wall St. on MSN
Abbott Labs vs. Danaher: Abbott’s everyday products beat Danaher’s slumping biotech equipment
Quick ReadAbbott (ABT) outpaced Danaher (DHR) as FreeStyle Libre delivered $2.08B while Cepheid respiratory revenue fell 25% on a soft flu season.Danaher's bioprocessing equipment orders surged over ...
Pharmaceutical and med device giant Abbott (NYSE: ABT) said today that it had received approval from the Food and Drug Administration (FDA) for its next-generation integrated continuous glucose ...
Data from Abbott’s REFLECT study show for the first time that the use of its continuous glucose monitoring technology, Freestyle Libre, can help lessen the severity of cardiovascular complications in ...
Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...
Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...
(Corrected) Abbott Diabetes Care has issued a recall of its FreeStyle Flash Blood Glucose Monitoring System and FreeStyle Blood Glucose Monitoring System. In addition, users of the Omnipod Insulin ...
This morning Abbott announced that its continuous glucose monitor the FreeStyle Libre 3 earned a CE mark, making it cleared for use for individuals with diabetes living in the European Union. This ...
MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...
Becton, Dickinson is a medical device manufacturer. The company has a large product portfolio, many of which are used daily by healthcare facilities. Becton, Dickinson is benefiting from the GLP-1 ...
Tandem Diabetes Care (TNDM) is back in focus after announcing that its t:slim X2 insulin pump with Control-IQ+ technology now ...
DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results